Home » Topics » BioWorld Science

BioWorld Science
RSS

Research on IL-38 mRNA expression in cancers supports Immunome's development of IMM-ONC-01

May 24, 2022

Anti-IL13RA1 eblasakimab reduces neuronal response to proinflammatory cytokines

May 24, 2022

PharmaCyte studies pancreatic cancer therapy to treat malignant ascites

May 24, 2022

Aptamer and PinotBio extend collaboration to develop Optimer-drug conjugates

May 24, 2022

KaliVir and Roche to collaborate on novel oncolytic vaccinia viruses

May 24, 2022

FDA grants orphan drug designation to DepYmed's DPM-1001 for Wilson disease

May 24, 2022

Salubris submits CTA in Europe for CTLA-4/IL-15 antibody fusion protein JK-08

May 24, 2022

AKAP11 is a risk gene shared by bipolar disorder and schizophrenia

May 24, 2022

Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1

May 24, 2022

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

May 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...